NeuroPace Inc — Director's Dealing 2022

Nov 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2022-11-21

Reporting Person: Accelmed Partners II L.P. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-21	Common Stock	P	327893	$1.499	Acquired	4370550	Direct
2022-11-22	Common Stock	P	62398	$1.499	Acquired	4432948	Direct

Footnotes

F1: Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Uri Geiger is the Managing Partner of Accelmed LLC. The address of each of Accelmed Partners II GP, LP and Accelmed Partners II LP is Ugland House, South Church Street, PO Box 309, Grand Cayman KY1-1104, Cayman Islands.